RAC 0.63% $1.59 race oncology ltd

Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-52

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 487 Posts.
    lightbulb Created with Sketch. 913
    Merchant sent out a round robin email advising us that they will be suggesting a small profit take (no surprises - that is always their model at times like this - and you can't blame them for that). This may be a trigger for some.

    However, never (in my mind) has there been a stronger case for not following a broker's advice blindly, which most have us have done at some time, I'm sure.

    I'm not selling a share. Not one. Any money I have invested in RACE, is staying there. I'm sure they don't need my modest investment, but it's staying where it is, and I selfishly get to go to bed at night thinking in some minor way, it helped deliver what I believe could be one of the biggest cancer treatment breakthroughs we will see in many years.

    I've everything crossed for you Dr T and team, that you can bring Bisantrene to the mass market on several fronts, and help potentially millions worldwide!!!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.